PL2376077T3 - Kompozycja i sposób leczenia cukrzycy - Google Patents
Kompozycja i sposób leczenia cukrzycyInfo
- Publication number
- PL2376077T3 PL2376077T3 PL10729620T PL10729620T PL2376077T3 PL 2376077 T3 PL2376077 T3 PL 2376077T3 PL 10729620 T PL10729620 T PL 10729620T PL 10729620 T PL10729620 T PL 10729620T PL 2376077 T3 PL2376077 T3 PL 2376077T3
- Authority
- PL
- Poland
- Prior art keywords
- diabetes
- treatment
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0031—Rectum, anus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US14395109P | 2009-01-12 | 2009-01-12 | |
| US29377310P | 2010-01-11 | 2010-01-11 | |
| EP10729620.4A EP2376077B1 (en) | 2009-01-12 | 2010-01-11 | Composition and method for treatment of diabetes |
| PCT/US2010/020629 WO2010081079A2 (en) | 2009-01-12 | 2010-01-11 | Composition and method for treatment of diabetes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2376077T3 true PL2376077T3 (pl) | 2017-10-31 |
Family
ID=42317190
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL10729620T PL2376077T3 (pl) | 2009-01-12 | 2010-01-11 | Kompozycja i sposób leczenia cukrzycy |
Country Status (22)
| Country | Link |
|---|---|
| US (2) | US8470885B2 (pl) |
| EP (1) | EP2376077B1 (pl) |
| JP (1) | JP5702306B2 (pl) |
| KR (4) | KR20190062609A (pl) |
| CN (1) | CN102355896A (pl) |
| AU (1) | AU2010203413B2 (pl) |
| BR (1) | BRPI1006145B8 (pl) |
| CA (1) | CA2748827C (pl) |
| CL (1) | CL2011001692A1 (pl) |
| CY (1) | CY1119010T1 (pl) |
| DK (1) | DK2376077T3 (pl) |
| EA (1) | EA022631B1 (pl) |
| ES (1) | ES2628233T3 (pl) |
| HR (1) | HRP20170886T1 (pl) |
| HU (1) | HUE034551T2 (pl) |
| LT (1) | LT2376077T (pl) |
| MX (1) | MX2011007393A (pl) |
| PL (1) | PL2376077T3 (pl) |
| PT (1) | PT2376077T (pl) |
| RS (1) | RS56054B1 (pl) |
| SI (1) | SI2376077T1 (pl) |
| WO (1) | WO2010081079A2 (pl) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010062863A2 (en) | 2008-11-26 | 2010-06-03 | Satiogen Pharmaceuticals, Inc. | Compositions containing satiogens and methods of use |
| US20150224081A1 (en) * | 2009-01-12 | 2015-08-13 | Biokier, Inc. | Composition and method for treatment of diabetes |
| WO2012161670A2 (en) | 2010-04-07 | 2012-11-29 | Incube Labs, Llc | Method for treating diabetes and other glucose regulation disorders using stem cells |
| EP2569430B1 (en) | 2010-05-12 | 2018-10-17 | The Trustees of Columbia University in the City of New York | Methods for producing enteroendocrine cells that make and secrete insulin |
| CN103702668A (zh) * | 2011-05-02 | 2014-04-02 | 拜奥基尔公司 | 治疗糖尿病的组合物和方法 |
| KR20130055220A (ko) | 2011-11-18 | 2013-05-28 | 삼성전자주식회사 | 동박적층판 및 이를 사용한 금속코어기판의 제조방법 |
| WO2013077893A1 (en) * | 2011-11-21 | 2013-05-30 | Emmaus Medical, Inc. | Methods and compositions for the treatment of diabetes and related symptoms |
| US20150073057A1 (en) * | 2013-09-06 | 2015-03-12 | Biokier, Inc. | Composition and method for treatment of diabetes |
| EP3160503B1 (en) | 2014-06-26 | 2021-02-17 | The Trustees of Columbia University in the City of New York | Inhibition of serotonin expression in gut enteroendocrine cells results in conversion to insulin-positive cells |
| US20180110823A1 (en) * | 2015-04-22 | 2018-04-26 | Cedars-Sinai Medical Center | Enterically delivered bitter oligopeptides for the treatment for type 2 diabetes |
| US11291693B2 (en) | 2015-06-25 | 2022-04-05 | Synlogic Operating Company, Inc. | Bacteria engineered to treat metabolic diseases |
| US9668991B1 (en) | 2015-12-09 | 2017-06-06 | International Business Machines Corporation | SCFA colonic composition |
| CN107684550B (zh) * | 2016-08-03 | 2020-04-10 | 徐天宏 | 糖尿病治疗产品及其制备与应用 |
| JOP20190146A1 (ar) | 2016-12-19 | 2019-06-18 | Axcella Health Inc | تركيبات حمض أميني وطرق لمعالجة أمراض الكبد |
| US20210084956A1 (en) | 2018-02-23 | 2021-03-25 | Ambra Bioscience Llc | Compositions and methods for hunger control and weight management |
| AR115585A1 (es) | 2018-06-20 | 2021-02-03 | Axcella Health Inc | Composiciones y métodos para el tratamiento de la infiltración de grasa en músculo |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA885473B (en) * | 1987-08-07 | 1989-03-29 | Century Lab Inc | Free fatty acids for treatment of diabetes mellitus |
| IT1245890B (it) | 1991-04-12 | 1994-10-25 | Alfa Wassermann Spa | Formulazioni farmaceutiche per uso orale gastroresistenti contenenti acidi biliari. |
| EP1003476B1 (en) | 1997-08-11 | 2004-12-22 | ALZA Corporation | Prolonged release active agent dosage form adapted for gastric retention |
| US6652882B1 (en) | 1997-10-06 | 2003-11-25 | Intellipharmaceutics Corp | Controlled release formulation containing bupropion |
| GB9722426D0 (en) | 1997-10-23 | 1997-12-24 | Univ London Pharmacy | Controlled release formulations |
| IL142650A (en) * | 1998-04-08 | 2007-06-03 | Galmed Int Ltd | Use of bile acid conjugates or bile salts and fatty acids or fatty acids in the preparation of pharmaceuticals for lowering cholesterol, for the treatment of fatty liver and for the treatment of hyperglycemia and diabetes |
| WO2000076478A1 (en) | 1999-06-14 | 2000-12-21 | Cosmo S.P.A. | Controlled release and taste masking oral pharmaceutical compositions |
| EP1364957B1 (en) | 2001-02-26 | 2008-12-31 | Kissei Pharmaceutical Co., Ltd. | Glycopyranosyloxypyrazole derivatives and medicinal use thereof |
| US20030203004A1 (en) * | 2002-04-24 | 2003-10-30 | Kelm Gary Robert | Compositions comprising short and long chain fatty acids and methods of their use for the management of body weight |
| US7135575B2 (en) * | 2003-03-03 | 2006-11-14 | Array Biopharma, Inc. | P38 inhibitors and methods of use thereof |
| PT1506963E (pt) | 2003-10-28 | 2005-08-31 | Adorkem Technology Spa | Processo para a preparacao de citalopram |
| ITMI20040187A1 (it) | 2004-02-06 | 2004-05-06 | Cosmo Spa | Composizioni farmaceutiche o dietetiche a base di acidi grassi a catena corta e zuccheri complessi per le disfunzioni intestinali |
| ITMI20041295A1 (it) | 2004-06-25 | 2004-09-25 | Cosmo Spa | Composizioni farmaceutiche antimicrobiche orali |
| JP2006056881A (ja) | 2004-07-21 | 2006-03-02 | Takeda Chem Ind Ltd | 縮合環化合物 |
| JP2006063064A (ja) | 2004-07-27 | 2006-03-09 | Takeda Chem Ind Ltd | 受容体作動剤 |
| CA2609394A1 (en) | 2005-05-23 | 2006-11-30 | Masaki Takagi | Pyrazole compound and therapeutic agent for diabetes comprising the same |
| DE102005046237A1 (de) | 2005-09-28 | 2007-04-05 | Südzucker Aktiengesellschaft Mannheim/Ochsenfurt | Buttersäureester von Kohlenhydraten und Kohlenhydratpolyolen |
| ITMI20052000A1 (it) * | 2005-10-21 | 2007-04-22 | Promefarm S R L | Compressa gastroresitente a base di butirrato di sodio |
| WO2007127505A2 (en) | 2006-01-20 | 2007-11-08 | Smithkline Beecham Corporation | Use of sulfonamide derivatives in the treatment of disorders of the metabolism and the nervous system |
| US20090035306A1 (en) | 2006-11-29 | 2009-02-05 | Kalypsys, Inc. | Quinazolinone modulators of tgr5 |
| EA016926B1 (ru) * | 2006-12-15 | 2012-08-30 | Тима Фаундейшн | Композиции для профилактики и лечения гипергликемии |
| WO2010062861A2 (en) | 2008-11-26 | 2010-06-03 | Satiogen Pharmaceuticals, Inc. | Bile acid recycling inhibitors for treatment of obesity and diabetes |
| WO2010062863A2 (en) | 2008-11-26 | 2010-06-03 | Satiogen Pharmaceuticals, Inc. | Compositions containing satiogens and methods of use |
| KR20140007973A (ko) | 2009-02-10 | 2014-01-20 | 아마린 파마, 인크. | 고중성지방혈증 치료 방법 |
| MY172372A (en) | 2009-06-15 | 2019-11-21 | Amarin Pharmaceuticals Ie Ltd | Compositions and methods for lowering triglycerides |
| WO2011038122A1 (en) | 2009-09-23 | 2011-03-31 | Amarin Corporation Plc | Pharmaceutical composition comprising omega-3 fatty acid and hydroxy-derivative of a statin and methods of using same |
-
2010
- 2010-01-11 PL PL10729620T patent/PL2376077T3/pl unknown
- 2010-01-11 CA CA2748827A patent/CA2748827C/en active Active
- 2010-01-11 KR KR1020197015093A patent/KR20190062609A/ko not_active Application Discontinuation
- 2010-01-11 PT PT107296204T patent/PT2376077T/pt unknown
- 2010-01-11 AU AU2010203413A patent/AU2010203413B2/en active Active
- 2010-01-11 CN CN201080004432XA patent/CN102355896A/zh active Pending
- 2010-01-11 BR BRPI1006145A patent/BRPI1006145B8/pt active IP Right Grant
- 2010-01-11 EP EP10729620.4A patent/EP2376077B1/en active Active
- 2010-01-11 HU HUE10729620A patent/HUE034551T2/en unknown
- 2010-01-11 DK DK10729620.4T patent/DK2376077T3/en active
- 2010-01-11 LT LTEP10729620.4T patent/LT2376077T/lt unknown
- 2010-01-11 MX MX2011007393A patent/MX2011007393A/es active IP Right Grant
- 2010-01-11 SI SI201031473T patent/SI2376077T1/sl unknown
- 2010-01-11 RS RS20170584A patent/RS56054B1/sr unknown
- 2010-01-11 KR KR1020177007518A patent/KR20170034928A/ko active Application Filing
- 2010-01-11 KR KR1020117015982A patent/KR20110120866A/ko active Application Filing
- 2010-01-11 US US13/143,766 patent/US8470885B2/en active Active
- 2010-01-11 EA EA201190068A patent/EA022631B1/ru unknown
- 2010-01-11 KR KR1020177034790A patent/KR20170138573A/ko active Search and Examination
- 2010-01-11 ES ES10729620.4T patent/ES2628233T3/es active Active
- 2010-01-11 WO PCT/US2010/020629 patent/WO2010081079A2/en active Application Filing
- 2010-01-11 JP JP2011545487A patent/JP5702306B2/ja active Active
-
2011
- 2011-07-11 CL CL2011001692A patent/CL2011001692A1/es unknown
-
2012
- 2012-10-08 US US13/646,778 patent/US8680085B2/en active Active
-
2017
- 2017-06-09 HR HRP20170886TT patent/HRP20170886T1/hr unknown
- 2017-06-12 CY CY20171100614T patent/CY1119010T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| LT2376077T (lt) | Kompozicija ir būdas, skirti diabetui gydyti | |
| EP2396019A4 (en) | METHOD AND COMPOSITIONS FOR SKIN TREATMENT | |
| EP2480246A4 (en) | COMPOSITION AND METHOD FOR THE TREATMENT OF DIABETES | |
| IL217292A0 (en) | Polypeptides and method of treatment | |
| HK1158522A1 (en) | Composition and method for treatment of mrsa | |
| HK1166280A1 (en) | Composition for treatment of tuberculosis | |
| EP2350641A4 (en) | Methods of Treatment | |
| EP2429584A4 (en) | TREATMENT PROCEDURE AND COMPOSITIONS | |
| GB0902040D0 (en) | Composition for treatment of skin | |
| HK1259004A1 (zh) | 治療糖尿病的組合物和方法 | |
| ZA201301936B (en) | Methods and compositions for treatment of diabetes and dyslipidemia | |
| ZA201303222B (en) | Composition and method for treating skin conditions | |
| EP2389171A4 (en) | USE OF PTEROSINE COMPOUNDS FOR THE TREATMENT OF DIABETES AND ADIPOSITAS | |
| HK1145454A1 (en) | Pharmaceutical composition for preventing and treating diabetic nephropathy and preparation method thereof | |
| ZA201203060B (en) | Composition and method of delivery | |
| EP2498787A4 (en) | COMPOSITIONS AND METHOD FOR SUGAR PROCESSING | |
| IL202002A0 (en) | Method of treating diabetes | |
| EP2473635A4 (en) | COMPOSITIONS AND METHODS FOR TREATMENT OF NEUROPATHIC PAIN | |
| EP2512504A4 (en) | COMPOSITION AND THERAPEUTIC METHOD | |
| EP2437771A4 (en) | COMPOSITIONS AND METHODS MODULATING MG29 FOR THE TREATMENT OF DIABETES | |
| EP2498794A4 (en) | METHOD FOR THE TREATMENT OF TYPE-2 DIABETES | |
| IL216456A0 (en) | Method of treating frailty | |
| EP2424539A4 (en) | PROCESS FOR TREATING DEPRESSION | |
| HK1170958A1 (en) | Compositions for treatment and prevention of diabetic complications using osteomeles schwerinae | |
| ZA200907778B (en) | Method of treating diabetes |